Nationwide surveillance of parenteral antibiotics containing meropenem activities against clinically isolated strains in 2009

Japanese Journal of Antibiotics

Volumn 64, Issue 2, 2011, Pages 53-95

  Yamaguchi, Keizo ^a   Ishii, Yoshikazu ^a   Iwata, Morihiro ^b   Watanabe, Naoki ^c   Shinagawa, Masaaki ^c   Yasujima, Minoru ^d   Suwabe, Akira ^e   Kuroda, Makiko ^e   Kaku, Mitsuo ^f   Kitagawa, Miho ^f   Kanemitsu, Keiji ^g   Imafuku, Yuji ^g   Murakami, Masami ^h   Yomoda, Sachie ⁱ   Taniguchi, Nobuyuki ^j   Yamada, Toshiyuki ^j   Nomura, Fumio ^k   Kanno, Harushige ^l   Maesaki, Shigefumi ^m   Hashikita, Giichi ^m   Kondo, Shigemi ⁿ   Misawa, Shigeki ^o   Horiuchi, Hajime ^p   Tazawa, Yoko ^p   Nakashima, Hideki ^q   Takemura, Hiromu ^q   Okada, Masahiko ^r   Horikawa, Yoshinori ^s   Maekawa, Masato ^t   Nagura, Osanori ^t   Yagi, Tetsuya ^u   Baba, Hisashi ^u   Ishigo, Shiomi ^v   Fujita, Naohisa ^w   Komori, Toshiaki ^w   Ichiyama, Satoshi ^x   Yamanaka, Kiyoharu ^y   Murata, Yoko ^y   Matsuo, Shuji ^z   Kohno, Hisashi ^z   Kawano, Seiji ^aa   Kinoshita, Shohiro ^aa   Taminato, Tomohiko ^ab   Negayama, Kiyoshi ^ab   Murase, Mitsuharu ^ac   Miyamoto, Hitoshi ^ac   Kusano, Nobuchika ^ad   Nose, Motoko ^ad   Yokozaki, Michiya ^ae   Itaha, Hideyuki ^ae   Matsunaga, Akira ^af   Yoshimura, Hisae ^af   Kohno, Shigeru ^ag   Yanagihara, Katsunori ^ag   Matsuda, Junichi ^ag   Saikawa, Tetsunori ^ah   Hiramatsu, Kazufumi ^ah   more..

^a TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

^c SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d HIROSAKI UNIVERSITY   (Japan)

^e IWATE MEDICAL UNIVERSITY   (Japan)

^f TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^g FUKUSHIMA MEDICAL UNIVERSITY   (Japan)

^h GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ GUNMA UNIVERSITY HOSPITAL   (Japan)

^j JICHI MEDICAL UNIVERSITY   (Japan)

^k CHIBA UNIVERSITY HOSPITAL   (Japan)

^l Takane Hospital   (Japan)

^m SAITAMA MEDICAL UNIVERSITY   (Japan)

ⁿ JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^o JUNTENDO UNIVERSITY HOSPITAL   (Japan)

^p Nippon Telegraph and Telephone Corporation Medical Center Tokyo   (Japan)

^q ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^r NIIGATA UNIVERSITY   (Japan)

^s NIIGATA UNIVERSITY MEDICAL AND DENTAL HOSPITAL   (Japan)

^t HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^u NAGOYA UNIVERSITY HOSPITAL   (Japan)

^v OGAKI MUNICIPAL HOSPITAL   (Japan)

^w KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^x KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^y Otemae Hospital   (Japan)

^z TENRI HOSPITAL   (Japan)

^aa KOBE UNIVERSITY HOSPITAL   (Japan)

^ab KAGAWA UNIVERSITY HOSPITAL   (Japan)

^ac EHIME UNIVERSITY HOSPITAL   (Japan)

^ad OKAYAMA UNIVERSITY HOSPITAL   (Japan)

^ae HIROSHIMA UNIVERSITY HOSPITAL   (Japan)

^af FUKUOKA UNIVERSITY HOSPITAL   (Japan)

^ag NAGASAKI UNIVERSITY HOSPITAL   (Japan)

^ah OITA UNIVERSITY HOSPITAL   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA LACTAMASE; CARBAPENEM; CIPROFLOXACIN; EXTENDED SPECTRUM BETA LACTAMASE; IMIPENEM; MEROPENEM; METALLO BETA LACTAMASE;

ANAEROBIC BACTERIUM; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; BACTEROIDES FRAGILIS; DRUG POTENCY; DRUG SURVEILLANCE PROGRAM; ENTEROBACTERIACEAE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HAEMOPHILUS INFLUENZAE; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; MULTIDRUG RESISTANCE; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CHILD; CHILD, PRESCHOOL; DOSAGE FORMS; DRUG RESISTANCE, BACTERIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; MIDDLE AGED; RESPIRATORY SYSTEM; THIENAMYCINS; TIME FACTORS; URINE; YOUNG ADULT;

EID: 79957442373     PISSN: 03682781     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Meropenem Chemotherapy 40 (suppl. 1): 74-89, 1992
2. Jpn. J. Antibiotics 57: 70-104, 2004
3. Jpn. J. Antibiotics 58: 655-689, 2005
4. Jpn. J. Antibiotics 60: 344-377, 2007
5. Chemotherapy 40 (suppl. 1): 222-237, 1992
6. LIVERMORE, D. M. & N. WOODFORD: The β-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 14: 213-220, 2006
7. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; Fourteenth informational supplement (NCCLS M100-S14), 2004
8. National Committee for Clinical Laboratory Standards: Performance standards for antimicrobial susceptibility testing; Nineteenth informational supplement (CLSI M100-S19), 2009
9. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard - seventh edition (NCCLS M7-A6), 2003
10. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard - sixth edition (NCCLS M11-A6), 2004
11. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; Approved standard - seventh edition (CLSI M7-A7), 2006
12. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria; Approved standard - seventh edition (CLSI M11-A7), 2007
13. PERILLI, M.; E. DELL'AMICO, B. SEGATORE, et al.: Molecular characterization of extended-spectrum β-lactamases produced by nosocomial isolates of Enterobacteriaceae from an Italian nationwide survey. J. Clin. Microbiol. 40: 611-614, 2002
14. STEWARD, C.D.; J. K. RASHEED, S. K. HUBERT, et al.: Characterization of clinical isolates of Klebsiella pneumoniae from 19 laboratories using the National Committee for Clinical Laboratory Standards extended-spectrum β-lactamase detection methods. J. Clin. Microbiol. 39: 2864-2872, 2001
15. BAUERNFEIND, A.; I. STEMPLINGER, R. JUNGWIRTH, et al.: Sequences of β-lactamase genes encoding CTX-M-1 (MEN-1) and CTX-M-2 and relationship of their amino acid sequences with those of other β-lactamases. Antimicrob. Agents Chemother. 40: 509-513, 1996
16. SABATE, M.; R. TARRAGO, F. NAVARRO, et al.: Cloning and sequence of the gene encoding a novel cefotaxime-hydrolyzing β-lactamase (CTX-M-9) from Escherichia coli in Spain. Antimicrob. Agents Chemother. 44: 1970-1973, 2000
17. SENDA, K.; Y. ARAKAWA, K. NAKASHIMA, et al.: Multifocal outbreaks of metallo β-lactamase-producing Pseudomonas aeruginosa resistant to broad-spectrum β-lactams, including carbapenems. Antimicrob. Agents Chemother. 40: 349-353, 1996
18. POIREL, L.; T. NAAS, D. NICOLAS, et al.: Characterization of VIM-2, a carbapenem-hydrolyzing metallo-β-lactamase and its plasmid- and integron-borne gene from a Pseudomonas aeruginosa clinical isolate in France. Antimicrob. Agents Chemother. 44: 891-897, 2000
19. SAITO, A.; T. INAMATSU, J. OKADA, et a.: Clinical breakpoints in pulmonary infections and sepsis: new antimicrobial agents and supplemental information for some agents already released. J. Infect. Chemother. 5: 223-226, 1999
20. Jpn. J. Antibiotics 61: 1-17, 2008
21. REYNOLDS, R.; N. POTZ, M. COLMAN, et al.: Antimicrobial susceptibility of the pathogens of bacteraemia in the UK and Ireland 2001-2002: the BSAC bacteraemia resistance surveillance programme. J. Antimicrob. Chemother. 53: 1018-1032, 2004
22. PFALLERA, M. A.; H. S. SADER, T. R. FRITSCHE, et al.: Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from north american hospitals: report from the SENTRY antimicrobial surveillance program (1998-2004). Diagn. Microbiol. Infect. Dis. 56: 63-68, 2006
23. PASCUALA, A.; E. PEREAA, M. ALVAREZ, et al.: The meropenem yearly susceptibility test information collection antimicrobial susceptibility program in Spain: a 5-year analysis. Diagn. Microbiol. Infect. Dis. 57: 195-200, 2007
24. PATZER, J. A.; D. DZIERZANOWSKA & P. J. TURNER: Trends in antimicrobial susceptibility of Gram-negative isolates from a paediatric intensive care unit in Warsaw: results from the MYSTIC programme (1997-2007). J. Antimicrob. Chemother. 62: 369-375, 2008
25. Jpn. J. Antibiotics 62: 346-370, 2009
26. Jpn. J. Antibiotics 62: 492-501, 2009
27. SUZUKI, S.; N. SHIBATA, K. YAMANE, et al.: Change in the prevalence of extended-spectrum-β-lactamase-producing E. coli in Japan by clonal spread. Antimicrob. Agents Chemother. 63: 72-79, 2009
28. CHONG, Y.; H. YAKUSHIJI, Y. ITO, et al.: Cefepime-resistant Gram-negative bacteremia in febrile neutropenic patients with hematological malignancies. Int. J. Infect. Dis. E171-E175, 2010
29. TRECARICHI, E. M.; M. TUMBARELLO, T. SPANU, et al.: Incidence and clinical impact of extended-spectrum-β-lactamase (ESBL) production and fluoroquinolone resistance in bloodstream infections caused by Escherichia coli in patients with hematological malignancies. J. Infect. 58: 299-307, 2009
30. SCHWABER, M. J. & Y. CARMELI: Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60: 913-920, 2007
31. NIKI, Y.; H. HANAKI, M. YAGISAWA, et al.: The first nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy. Part 1 : a general view of antibacterial susceptibility. J. Infect. Chemother. 14: 279-290, 2008
32. NIKI, Y.; H. HANAKI, T. MATSUMOTO, et al.: Nationwide surveillance of bacterial respiratory pathogens conducted by the Japanese Society of Chemotherapy in 2007: general view of the pathogens' antibacterial susceptibility. J. Infect. Chemother. 15: 156-157, 2009
33. KIMURA, S.; J. ALBA, K. SHIROTO, et al.: Clonal diversity of metallo-β-lactamase-possessing Pseudomonas aeruginosa in geo-graphically diverse regions of Japan. J. Clin. Microbiol. 43: 458-461, 2005
34. RHOMBERG, P. R. & R. N. JONES: Summary trends for the meropenem yearly susceptibility test information collection program: a 10-year experience in the United States. Diagn. Microbiol. Infect. Dis. 65: 414-426, 2009